Browse Drug Recalls

7 FDA drug safety recalls.

FDA Drug Recall Enforcement Database

Browse 7 FDA drug recall enforcement actions. Each entry includes the product description, reason for recall, classification (Class I through III based on severity), recalling firm, and distribution details. Use the filters below to search by year, classification, state, or keyword.

Drug Safety Recalls

Browse 7 FDA drug recalls.

Clear
DateProductReasonClassFirm
Mar 15, 2021 Verapamil Hydrochloride Extended-Release Tablets USP 120 mg Rx Only NDC 68462... CGMP Deviations: Intermittent exposure to temperature excursion during storage. Class II Cardinal Health Inc.
Mar 18, 2014 Ranitidine Tablets USP, 150 mg, 500-count bottles, Rx only, Manufactured by: ... Presence of Foreign Tablets/Capsules: Recall is due to a pharmacist complaint of a "foreign mater... Class II Glenmark Generics Inc., USA
Apr 5, 2013 Glenmark Topiramate Tablets, 200 mg, 60-count bottle, (NDC 68462-110-60), Rx... Chemical Contamination: Topiramate Tablets is being recalled due to complaints related to an off ... Class III Glenmark Generics Inc., USA
Apr 5, 2013 Glenmark Pravastatin Sodium Tablets ,40 mg, 90-count bottle (NDC 68462-197-90... Chemical Contamination: Pravastatin Sodium Tablets isbeing recalled due to complaints related to ... Class III Glenmark Generics Inc., USA
Apr 5, 2013 Glenmark Gabapentin Tablets, a) 600mg, 500- count bottle (NDC 68462-126-05)... Chemical Contamination: Gabapentin Sodium tablets is recalled due to complaints related to an off... Class III Glenmark Generics Inc., USA
Feb 13, 2013 Montelukast Sodium Tablets, 10 mg (base), packaged in a) 30-count tablets per... Chemical Contamination: The recall has been initiated based on multiple complaints received from ... Class III Glenmark Generics Inc., USA
Jul 6, 2012 NAPROXEN TABLETS USP, 500 mg, 100-count Tablets per bottle, Rx only, Manufact... Labeling: Label Mix-Up: Bottles labeled as Naproxen Tablets USP, 500 mg, 100-count may contain 90... Class II Glenmark Generics Inc., USA

Frequently Asked Questions

When a drug safety issue is identified — through FDA inspections, laboratory testing, adverse event reports, or manufacturer quality checks — the responsible company issues a recall to remove the affected products from the market. Pharmacies pull the product from shelves, and consumers are advised to contact their healthcare provider for alternatives.

The leading causes include cGMP deviations, impurity contamination (including nitrosamines like NDMA), failed dissolution or stability testing, sterility issues, potency problems, labeling errors, and foreign particle contamination.

Use the search and filter tools on this page to look up specific medications, active ingredients, or manufacturers. Each recall entry includes the product description, lot numbers, and distribution details.